Hyderabad, Andhra Pradesh -- (SBWIRE) -- 03/29/2012 -- ReportReserve announces the inclusion of its new report Pharmaceuticals and Healthcare Industry TechNavio’s analysts forecast the Global Atrial Fibrillation market to grow at a CAGR of 14 percent over the period 2010–2014. One of the key factors contributing to this market growth is the emergence of new anti-arrhythmic and anti-coagulant agents for atrial fibrillation. The Global Atrial Fibrillation market has also been witnessing an increase in the number of clinical trials of atrial fibrillation devices and drugs. However, the unorganized market in the APAC region could pose a challenge to the growth of this market.

TechNavio’s report, Global Atrial Fibrillation Market 2010–2014, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Atrial Fibrillation market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include St. Jude Medical Inc., Boston Scientific Corp., Biosense Webster Inc., C.R. Bard Inc., and Medtronic Inc.

Key questions answered in this report:
- What will the market size be in 2014 and at what rate will it grow?
- What key trends is this market subject to?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the opportunities and threats faced by each of these key vendors?
- What are the strengths and weaknesses of each of these key vendors?

For further information click on http://www.reportreserve.com/report/global-atrial-fibrillation-market-2010%E2%80%932014-report-524158